Iovance Biotherapeutics Inc. buy BiotechBee
Start price
24.06.23
/
50%
€7.14
Target price
30.11.25
€9.00
Performance (%)
7.45%
End price
14.12.24
€7.67
Summary
This prediction ended on 14.12.24 with a price of €7.67. With a performance of 7.45%, the BUY prediction by BiotechBee for Iovance Biotherapeutics Inc. closed with a slight gain. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | -6.657% | -6.657% | 19.822% |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
According to BiotechBee what are the pros and cons of Iovance Biotherapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Lion Biotechnologies Inc diskutieren
Buy mit Kursziel 9,0
In the thread Trading Lion Biotechnologies Inc
Buy beendet

